Metroprolol succinate CAS NO.98418-47-4

english name: metroprolol succinate

english synonyms: metoprolol succinate; metroprolol succinate; metoprolol succinate (200 mg); metoprolol succinate (200 mg) f0c4150.998 mg/mg (ai); 2-propanol, 1-(4-(2-methoxyethyl)phenoxy)-3- ((1-methylethyl)amino)-, (+-)-, butanedioate (2:1) (salt);metoprolol succinate (toprolx);rolol succinate

cas number: 98418-47-4

molecular formula: 2c15h25no3.c4h6o4

molecular weight: 652.82

standard:bp

assay:99%

appearance:white powder

usage: hypertension medication.

 

description:

metoprolol is a selective β 1 blocker that requires a dose of the cardiac β 1 receptor that is required to produce a dose that is lower than its peripheral vascular and bronchial β 2 receptors. the selectivity of metoprolol succinate is dose-dependent, as the peak plasma concentration of sustained-release tablets is significantly lower than that of normal tablets at the same dose, giving the dosage form a relatively higher selectivity for β 1 receptors. metoprolol has no β-agonist effect and almost no membrane activation. beta-blockers have negative inotropic and time-varying effects. treatment with metoprolol can attenuate the effects of catecholamines associated with physiological and psychological burdens and reduce heart rate, cardiac output, and blood pressure. under stress, adrenal secretion from the adrenal gland increases, and metoprolol does not interfere with physiological vasodilation.

 

application:

an api for angina pectoris, hypertension treatment. metoprolol is a selective β1-blocker and is one of the commonly used drugs for the treatment of hypertension, chronic heart failure and arrhythmia. it is commonly used in the treatment of hypertension, chronic heart failure and arrhythmias.

 

kern Enterprises Co. LTD is committed to the development of import and export trade in the production, operation and plant extracts of pharmaceutical raw materials and intermediates. it has trade with other asian countries and europe, the americas and african countries. important exporters of pharmaceutical chemical raw materials and the world's latest importers of pharmaceutical raw materials.

kern Enterprises Co. LTD has always been adhering to the company to market-oriented, customer-centric, with professional and enterprising team spirit and the company's strong financial strength, to provide customers with fast, high quality and efficient services, and always " to benefit customers "for the purpose.

in the pharmaceutical raw materials and intermediates export business, the company by virtue of years of accumulated experience and high quality and reasonable talent structure, accurate grasp of the market, not only with a number of well-known domestic production enterprises to establish a long-term stable strategic cooperative relations in the global pharmaceutical chemical raw materials and chemical intermediates on the market also won the loyal customer base and a very strong strategic partner, set up a professional image of the outsourcing of pharmaceutical procurement. on the basis of continuing to develop the existing export trade business, the company has formulated the idea of establishing independent research and development center and constructing the production base of pharmaceutical and chemical products according to the future development trend of the pharmaceutical and chemical industry, and strives to establish the combination of r & d, manufacturing and trade of the business development model.

while actively expanding their business and creating economic profits, enterprises do not forget their social responsibility, and actively participate in greening trees, poor students and other social activities, and become a tradition for many years, creating a good social benefits.

Contact  skype:globalrcfactory